# LumiraDx
> LumiraDx offers rapid, lab-comparable diagnostic tests. The provided context highlights the LumiraDx SARS-CoV-2 Ag Test, an easy-to-use, fast microfluidic immunofluorescence assay designed for rapid detection of nucleocapsid protein antigen in swab specimens, providing actionable results in just 12 minutes.
- URL: https://optimly.ai/brand/lumiradx
- Logo: https://logo.clearbit.com/https://diagnostics.roche.com/us/en/c/lumira-sars-cov-2-ag-test.html
- Slug: lumiradx
- BAI Score: 40/100
- Archetype: Incumbent
- Category: Healthcare
- Last Analyzed: July 26, 2026
## Buyer Intent Signals
Problems: Traditional RT-PCR lab testing: Sending samples to a central laboratory for RT-PCR testing, which is highly accurate but typically involves longer turnaround times for results compared to point-of-car | No rapid testing: Foregoing rapid diagnostic testing, which could lead to delays in identifying infected individuals, increased potential for disease transmission, and delayed treatment decisions.
Solutions: LumiraDx SARS-CoV-2 Ag Test | rapid COVID-19 antigen test | Roche point of care COVID test | Other rapid antigen tests or molecular point-of-care tests: Utilizing alternative rapid antigen or rapid molecular tests from other manufacturers that offer similar point-of-care diagnostic capabiliti